Biofrontera (BFRI) Other Non Operating Income (2020 - 2025)
Biofrontera's (BFRI) quarterly Other Non Operating Income came in at $341000.0 in Q4 2025, down 28.06% year-on-year from $474000.0 in Q4 2024, and up 1036.67% quarter-over-quarter from $30000.0 in Q3 2025.
Biofrontera (BFRI) Other Non Operating Income (2020 - 2025) Analysis & Trends
Biofrontera's Other Non Operating Income history runs 6 years deep, the most recent figure standing at $341000.0 for Q4 2025.
- On a quarterly basis, Other Non Operating Income fell 28.06% year-over-year to $341000.0 in Q4 2025; TTM through Dec 2025 was $8000.0, a 93.94% decrease from a year earlier, with the FY2025 full-year figure at $8000.0, down 94.94% from the prior year.
- Other Non Operating Income improved to $341000.0 in Q4 2025 per BFRI's latest filing, from $30000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $474000.0 in Q4 2024 and bottomed at -$316000.0 in Q1 2024.
- The 5-year median for Other Non Operating Income is $26000.0 (2022), against an average of $39300.0.
- Across the five-year window, Other Non Operating Income slumped 4766.67% in 2023 and jumped 438.57% in 2024, its largest moves.
- Year by year, Other Non Operating Income stood at $270000.0 in 2021, then tumbled by 98.89% to $3000.0 in 2022, then slumped by 4766.67% to -$140000.0 in 2023, then soared by 438.57% to $474000.0 in 2024, then retreated by 28.06% to $341000.0 in 2025.
- Per Business Quant, the three latest BFRI Other Non Operating Income figures stand at $341000.0 (Q4 2025), $30000.0 (Q3 2025), and -$264000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Biofrontera | 12.70 Mn | 6.29 Mn | 14.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 341,000.00 |
| Sep 30, 2025 | 30,000.00 |
| Jun 30, 2025 | -264,000.00 |
| Mar 31, 2025 | -99,000.00 |
| Dec 31, 2024 | 474,000.00 |
| Sep 30, 2024 | -32,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Mar 31, 2024 | -316,000.00 |
| Dec 31, 2023 | -140,000.00 |
| Sep 30, 2023 | 35,000.00 |
| Jun 30, 2023 | 62,000.00 |
| Mar 31, 2023 | -33,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Sep 30, 2022 | -22,000.00 |
| Jun 30, 2022 | 29,000.00 |
| Mar 31, 2022 | 23,000.00 |
| Dec 31, 2021 | 270,000.00 |
| Sep 30, 2021 | 185,000.00 |
| Jun 30, 2021 | 155,000.00 |
| Mar 31, 2021 | 79,000.00 |